Hypopnea is a condition characterized by a partial decrease in breathing during sleep. Airflow does not stop completely but decreases by at least 30%, and is typically accompanied by a drop in blood oxygen levels.
It is usually characterized by a decrease in airflow lasting at least 10 seconds, accompanied by a drop in blood oxygen levels or an arousal response (micro-awakenings). Hypopnea is generally considered a component of sleep apnea syndrome and is counted alongside apneas when calculating the Apnea-Hypopnea Index (AHI). Although it may seem mild on its own, frequent episodes can significantly impair sleep quality.
Symptoms include fragmented sleep throughout the night, waking up tired in the morning, headaches, excessive daytime sleepiness, inattention, and difficulty concentrating. In some individuals, snoring, night sweats, and dry mouth may also be present. Hypopnea episodes are generally not noticed by the individual; they are often investigated due to complaints of irregular breathing or snoring reported by a partner.
What Is Hypopnea?
Hypopnea is a condition in which breathing does not completely stop during sleep but is significantly reduced. It is typically characterized by a decrease in blood oxygen levels or a brief arousal response, accompanied by a drop in airflow lasting at least 10 seconds. It is considered a component of sleep apnea syndrome and is included in the calculation of the Apnea-Hypopnea Index (AHI) along with apneas. When it occurs frequently, it can impair sleep quality and lead to complaints such as daytime fatigue and decreased attention.
Hypopnea typically arises due to partial narrowing of the upper airway and is most commonly seen in conjunction with obstructive sleep apnea. The individual does not stop breathing completely, but breathing becomes shallow, and since the body cannot obtain sufficient oxygen, the brain sends a brief wake-up signal. This situation can recur numerous times throughout the night and disrupts sleep continuity without being noticed. If left untreated over the long term, it may be associated with chronic fatigue, concentration difficulties, and an increased risk of cardiovascular disease.
Definition of Hypopnea
Hypopnea is a respiratory event characterized by a significant reduction in airflow rather than a complete cessation of airflow during sleep. According to polysomnographic criteria, it is typically associated with a decrease in airflow of at least 30%, a drop in oxygen saturation (≥3–4%), or electroencephalographic arousal, lasting at least 10 seconds. Unlike apnea, ventilation does not completely cease; however, alveolar ventilation decreases, and intermittent hypoxemia may develop as a result. Hypopneas, along with apneas, are included in the calculation of the Apnea-Hypopnea Index (AHI) and are considered one of the fundamental parameters in the diagnosis and severity classification of sleep-related breathing disorders.
Hypopnea events may develop due to obstructive or central mechanisms; in obstructive hypopnea, airflow decreases due to partial narrowing of the upper airway while respiratory effort persists, whereas in central hypopnea, a decrease in respiratory effort is also observed. Recurrent hypopneas can disrupt sleep architecture, leading to frequent micro-awakenings, increased sympathetic activity, and cardiovascular stress. Therefore, in clinical evaluation, not only complete apneas but also the frequency of hypopneas and the accompanying level of oxygen desaturation should be analyzed in detail.
The Difference Between Apnea and Hypopnea
Apnea and hypopnea are respiratory disorders observed during sleep, but there is a fundamental difference in severity between them. Apnea is the complete cessation of airflow for at least 10 seconds; hypopnea, however, is not a complete cessation of breathing but a significant reduction in it. While ventilation drops to zero during apnea, partial airflow continues during hypopnea, though oxygen desaturation and micro-awakenings may occur. Both conditions are evaluated together in the calculation of the Apnea-Hypopnea Index (AHI) and are used to determine the severity of sleep apnea. Although hypopnea may appear milder clinically, when it occurs frequently, it can cause physiological effects as serious as apnea.
From a physiological perspective, during apnea, both airflow is completely interrupted and, in some types (central apnea), respiratory effort may cease; in hypopnea, however, while airflow is reduced, it does not completely disappear. While apneas generally cause more pronounced drops in oxygen levels, hypopneas can lead to milder but more frequent episodes of desaturation. Therefore, in clinical evaluation, not only complete cessation of breathing but also the frequency and duration of partial reductions are of great importance; because together they constitute the total burden of respiratory disturbance.
What is the AHI (Apnea-Hypopnea Index)?
The AHI (Apnea-Hypopnea Index) is a measure representing the total number of apneas and hypopneas occurring per hour during sleep. It is calculated during a sleep study (polysomnography) and serves as the primary criterion for determining the presence and severity of sleep apnea. An AHI value below 5 is considered normal; values between 5 and 15 are classified as mild, between 15 and 30 as moderate, and above 30 as severe sleep apnea. This index is a key parameter in determining the need for treatment and evaluating the effectiveness of the treatment administered.
Although the AHI value alone is diagnostic, it is evaluated in conjunction with clinical symptoms and oxygen desaturation levels. This is because in some patients, even if the AHI is at a moderate level, significant daytime sleepiness, cardiac arrhythmias, or severe drops in oxygen levels may still be observed. Additionally, since the AHI reflects an average value over the duration of sleep, the distribution of events (such as an increase during REM sleep or a concentration in the supine position) is also considered in treatment planning. For this reason, the AHI is a fundamental clinical indicator in both the diagnosis and monitoring of sleep-related breathing disorders.
| AHI Value (Per Hour) | Severity Level | Clinical Assessment |
|---|---|---|
| 0 – 4.9 | Normal | No clinically significant sleep apnea |
| 5 – 14.9 | Mild | Mild sleep apnea |
| 15–29.9 | Moderate | Moderate sleep apnea |
| 30 and above | Severe | Severe sleep apnea |
What Are the Symptoms of Hypopnea?
Symptoms of hypopnea often develop unnoticed throughout the night but can significantly affect both sleep quality and daytime performance. Shallow and inadequate breathing leads to a drop in blood oxygen levels and frequent micro-awakenings. This condition can cause complaints such as waking up feeling unrested, headaches, and dry mouth. During the day, excessive sleepiness, fatigue, difficulty concentrating, forgetfulness, and trouble focusing may occur. In some individuals, snoring, night sweats, and restless sleep may also accompany these symptoms. Symptoms may be mild, but if they persist over a long period, they can seriously affect quality of life.
Hypopnea episodes are generally not noticed by the individual themselves; they often come to light through complaints of irregular breathing and snoring observed by a spouse or family members. Repeated drops in oxygen levels throughout the night can lead to fluctuations in heart rate and sleep disruptions. If left untreated over the long term, it may be associated with chronic fatigue, decreased work performance, and an increased risk of cardiovascular disease. Therefore, a detailed evaluation is particularly important for individuals who wake up tired in the morning or experience unexplained drowsiness during the day.
What Causes Hypopnea?
Hypopnea typically arises due to partial narrowing of the upper airway during sleep. The relaxation of throat muscles during sleep may not cause the airway to close completely but can lead to significant narrowing, resulting in shallow breathing. The most common cause is anatomical narrowing associated with obstructive sleep apnea. Factors such as obesity, a thick neck circumference, enlarged tonsils, a small jaw structure, and nasal congestion increase the risk.
Less commonly, hypopnea may develop due to central nervous system-related respiratory control disorders. In this case, the brain cannot send sufficient signals to the respiratory muscles, resulting in reduced respiratory depth. Heart failure, neurological diseases, and certain medications (particularly opioids and sedatives) may also play a role in the development of hypopnea. Additionally, alcohol use and sleeping on one’s back can trigger hypopnea episodes by increasing airway resistance.
Obesity
Obesity is one of the most significant risk factors for hypopnea and obstructive sleep apnea. An increase in fat tissue around the neck and upper airway can cause the airway to narrow during sleep. This narrowing becomes more pronounced when lying on the back, as the throat muscles relax, leading to shallow breathing. Additionally, abdominal fat can restrict diaphragm movement, thereby reducing lung capacity. While the frequency of hypopnea generally increases with weight gain, controlled weight loss can help reduce respiratory events and improve sleep quality.
Obesity can also negatively affect the cardiovascular system by increasing systemic inflammation and insulin resistance; this situation increases the burden on the body caused by oxygen fluctuations during sleep. An increased body mass index (BMI) is directly associated with elevated Apnea-Hypopnea Index (AHI) values. Therefore, weight management is a crucial treatment step not only for general health but also for reducing the severity of sleep-related breathing disorders. A proper nutrition plan and regular physical activity can help reduce the frequency of hypopnea episodes.
Upper Airway Narrowing
Upper airway narrowing is one of the most common causes of hypopnea and becomes evident due to the relaxation of throat muscles during sleep. Instead of the airway closing completely, its partial narrowing leads to shallow breathing and reduced airflow. A small jaw structure, enlarged tonsils, a receding tongue base, nasal congestion, or anatomical narrowings can contribute to this condition. The narrowing of the airway, combined with reduced muscle tone during sleep, can cause a drop in oxygen levels and micro-awakenings, thereby impairing sleep quality.
Upper airway narrowing may become more pronounced, particularly in the supine position; due to the effects of gravity, the base of the tongue and the soft palate shift backward, narrowing the airway. Conditions affecting the nasal passages, such as allergic rhinitis, chronic sinusitis, or a deviated nasal septum, can also reduce airflow and increase the frequency of hypopnea episodes. Therefore, anatomical evaluation and planning for medical or surgical intervention when necessary play a crucial role in improving respiratory flow.
Nasal Obstruction
Nasal obstruction can contribute to the development of hypopnea by reducing airflow during sleep. Narrowing of the nasal passage leads the individual to breathe through the mouth and increases resistance in the upper airway. This situation can cause shallow breathing, snoring, and fluctuations in oxygen levels. Allergic rhinitis, chronic sinusitis, enlarged turbinates, and a deviated septum are common causes of nasal congestion. Congestion that worsens at night, in particular, can impair sleep quality, leading to frequent micro-awakenings and waking up feeling unrested.
When nasal congestion persists for an extended period, it can cause an increase in negative pressure in the upper airway, creating conditions that make the airway narrow more easily. In individuals with existing anatomical predispositions, this can increase the frequency of hypopnea and obstructive breathing events. Opening the nasal passages through appropriate medical treatment (allergy control, nasal sprays, etc.) or, when necessary, surgical intervention can improve nighttime breathing quality and reduce sleep disruptions.
Genetic Factors
Genetic factors may play a significant role in the development of hypopnea and sleep-related breathing disorders. It is known that the risk is higher in individuals with a family history of sleep apnea. Structural characteristics affecting the upper airway—such as jaw structure, the shape of facial bones, and the anatomy of the tongue and soft palate—may be hereditary. These anatomical predispositions can create conditions that make the airway narrow more easily during sleep and lead to shallower breathing.
In addition, genetic factors may influence not only anatomical structure but also respiratory control mechanisms and fat distribution. Characteristics such as a predisposition to obesity, differences in muscle tone, and the respiratory center’s sensitivity to carbon dioxide may also contain genetic components. Therefore, evaluating symptoms at an early stage in individuals with a family history is important for the timely detection of potential sleep disorders.
Alcohol and Tobacco Use
Alcohol use can reduce muscle tone during sleep, making it easier for the upper airway to narrow. Alcohol consumed before bedtime, in particular, increases the relaxation of throat muscles and raises airway resistance. This can increase the frequency and duration of hypopnea episodes and make oxygen desaturations more pronounced. Additionally, alcohol can disrupt sleep architecture, leading to more superficial and fragmented sleep.
Smoking, on the other hand, can narrow the airway by causing chronic inflammation and mucosal edema in the respiratory tract. Long-term smoking causes structural changes in the nose and upper airway, increasing respiratory resistance. This creates conditions for reduced airflow during sleep and an increase in hypopnea events. Quitting alcohol and smoking is an important step toward improving both overall health and sleep quality.
Neurological Causes
Neurological causes are rarer but clinically significant causes of hypopnea. The respiratory centers located in the brainstem are responsible for the automatic regulation of breathing. Stroke, tumors, trauma, or degenerative diseases affecting these regions can disrupt respiratory control, leading to a decrease in respiratory depth. In such cases, even if the airway remains open, hypopnea episodes may occur because the brain cannot send sufficient and regular signals to the respiratory muscles.
Additionally, neurological diseases such as Parkinson’s disease, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) can also affect the coordination of respiratory muscles. A weakened response of the respiratory center to carbon dioxide can cause ventilation to become shallow during sleep. Therefore, sleep quality and nocturnal breathing patterns should be carefully evaluated in individuals with neurological disorders.
The Relationship Between Hypopnea and Sleep Apnea
Hypopnea and sleep apnea are closely related concepts and are generally evaluated together. Sleep apnea refers to the general condition where breathing is repeatedly disrupted during sleep; these disruptions can manifest as apnea (complete cessation) and hypopnea (partial reduction). In other words, hypopnea is a component of the sleep apnea syndrome. During a sleep study, both events are counted together to calculate the Apnea-Hypopnea Index (AHI), and the severity of the condition is determined based on this total value.
Clinically, while hypopnea may appear milder than apnea, it can produce similar physiological effects when it occurs frequently. Recurrent drops in oxygen levels and micro-awakenings disrupt sleep continuity, leading to excessive daytime sleepiness, reduced attention, and increased cardiovascular stress. Therefore, not only complete breathing pauses but also partial reductions play a significant role in diagnosis and treatment planning.
How Is Hypopnea Diagnosed?
The diagnosis of hypopnea is made through an evaluation of the patient’s clinical complaints and objective sleep tests. Symptoms such as waking up tired in the morning, excessive daytime sleepiness, snoring, and difficulty concentrating raise suspicion of a sleep-related breathing disorder. However, symptoms alone are insufficient for a definitive diagnosis; respiratory events must be measured.
The gold standard method for diagnosis is known as polysomnography (overnight sleep study). During this test, airflow, respiratory movements, oxygen saturation, heart rate, and brain waves are recorded. Hypopnea is defined as a respiratory event typically lasting at least 10 seconds, characterized by a decrease in airflow accompanied by a drop in oxygen levels or a micro-awakening. The data obtained is used to calculate the Apnea-Hypopnea Index (AHI), and the severity of the condition is determined accordingly.
Hypopnea Treatment
Hypopnea treatment is planned based on the underlying cause and the severity of the respiratory events. The most commonly preferred method is the use of positive pressure ventilation devices. In particular, CPAP therapy prevents shallow breathing by keeping the airway open during sleep and helps maintain stable oxygen levels.
With appropriate pressure settings, hypopnea episodes can be significantly reduced, and sleep quality can be improved.
In addition, lifestyle changes such as weight management, reducing alcohol consumption, quitting smoking, and adjusting sleep position support the treatment. If structural issues such as nasal congestion or anatomical narrowing are present, medical or surgical options may be considered. The treatment plan should be tailored to the individual and its effectiveness evaluated through regular follow-up; this ensures both improved nighttime breathing quality and enhanced daytime performance.
CPAP Device
CPAP (Continuous Positive Airway Pressure) is a respiratory support device that delivers air at a constant and steady pressure to keep the airway open during sleep. The positive pressure applied via a mask prevents narrowing of the upper airway, thereby reducing episodes of apnea and hypopnea. It is recognized as the first-line treatment for obstructive sleep apnea and hypopnea. When used regularly and correctly, it balances oxygen levels, reduces nighttime awakenings, and helps improve excessive daytime sleepiness. The device’s effectiveness can be enhanced through proper mask selection and personalized pressure settings.
For CPAP therapy to be successful, it is important to use the device every night for a sufficient duration. There may be an adjustment period with the mask in the first few days; however, selecting the correct mask type and using a humidifier can enhance comfort. With regular use, snoring decreases, hypopnea and apnea episodes are controlled, and sleep continuity improves. Additionally, adherence to treatment contributes to reducing cardiovascular risks in the long term and improving overall quality of life.
Weight Loss
Weight loss is an important and supportive approach in the treatment of hypopnea and obstructive sleep apnea. In particular, a reduction in fat tissue around the neck and upper airway helps keep the airway more open during sleep. Additionally, a reduction in abdominal fat relieves diaphragm movements and positively affects lung capacity. Studies have shown that a controlled reduction in body weight can lead to a decrease in Apnea-Hypopnea Index (AHI) values. Weight loss achieved through a balanced diet and regular physical activity contributes to improving both respiratory quality and overall health.
Weight management also helps reduce blood pressure, insulin resistance, and cardiovascular risk factors; this can mitigate the adverse effects of oxygen fluctuations on the body during sleep. Especially in individuals experiencing hypopnea related to obesity, a sustainable weight loss process planned under medical supervision can enhance treatment success. While weight loss significantly reduces respiratory events in some patients, more effective results can be achieved when combined with device therapy in advanced cases.
Intraoral Devices
Intraoral appliances are alternative treatment options used particularly in cases of mild to moderate hypopnea or obstructive sleep apnea. These specialized devices gently position the lower jaw forward, preventing the base of the tongue from falling backward and keeping the upper airway more open. This increases airflow during sleep and may reduce shallow breathing. They are typically custom-made by a dentist based on individual measurements and require regular use.
These devices may be a suitable option for patients who cannot adapt to a CPAP machine or who have milder respiratory disorders. Proper patient selection and regular follow-up are crucial for treatment success. Some individuals may experience temporary side effects such as jaw pain, tooth sensitivity, or increased saliva production; however, these issues can usually be managed with appropriate adjustments.
Surgical Intervention
Surgical intervention is an option considered when there is a significant underlying anatomical narrowing in hypopnea and obstructive sleep apnea, and sufficient benefit cannot be achieved with other treatment methods. The goal is to increase airflow by removing structural obstructions in the upper airway. Issues such as enlarged tonsils and adenoids, soft palate prolapse, nasal septum deviation, or narrowing related to jaw structure can be corrected through surgery. Appropriate patient selection is of great importance for success rates.
Surgical options are tailored to the individual and evaluated by otolaryngologists or maxillofacial surgeons. Surgery may not provide a definitive solution on its own for every patient; in some cases, additional treatments may be required after surgery. Therefore, the decision to undergo surgery should be made following sleep test results and a comprehensive clinical evaluation. When performed with the correct indication, it can improve breathing quality by increasing airway patency.
Lifestyle Changes
Lifestyle changes play a significant supportive role in managing hypopnea and sleep-related breathing disorders. In particular, establishing regular sleep schedules, maintaining a healthy weight, and following a balanced diet contribute to the healthier functioning of the respiratory system. Limiting alcohol consumption and avoiding sedative substances before bedtime can help maintain upper airway muscle tone. Additionally, regular physical activity supports weight management and improves cardiovascular health.
Adjusting sleep position is also a key factor; since sleeping on one’s back may increase airway narrowing in some individuals, sleeping on one’s side may be recommended. Quitting smoking can improve airflow by reducing inflammation in the upper airway. While these changes may not be sufficient on their own in advanced cases, when combined with medical or device-based treatments, they increase treatment success and can significantly improve sleep quality in the long term.
Is Hypopnea Dangerous?
Since hypopnea involves a reduction rather than a complete cessation of breathing, it may be perceived as a mild condition; however, when it occurs frequently, it can lead to serious health consequences. Oxygen drops and repeated micro-awakenings during sleep disrupt sleep continuity, potentially causing chronic fatigue, decreased attention, and excessive daytime sleepiness. This condition can significantly impact quality of life.
In the long term, untreated and high-frequency hypopnea episodes can place additional strain on the cardiovascular system. Fluctuations in oxygen levels may contribute to irregular heart rhythms, blood pressure changes, and increased metabolic stress. Therefore, appropriate evaluation and treatment planning are particularly important in cases of moderate to severe hypopnea. Early diagnosis can reduce risks and significantly improve sleep quality.
How Many Hypopneas Constitute a Risk?
The risk level of hypopnea is assessed not by the number of events alone, but by the Apnea-Hypopnea Index (AHI) value, which indicates the total number of apneas and hypopneas per hour. An AHI value below 5 is generally considered normal. Sleep-related breathing disorders are classified as mild (5–15 per hour), moderate (15–30 per hour), and severe (over 30 per hour). The risk increases as this value rises.
However, it is not just the number that matters; the degree of oxygen desaturation and the individual’s clinical symptoms are also important. Clinical risk may increase if there is significant oxygen desaturation or excessive daytime sleepiness despite a low AHI value. Particularly in individuals with heart disease, hypertension, or metabolic disorders, careful evaluation is necessary even at lower thresholds. Therefore, risk assessment must be conducted by considering both sleep test results and the clinical picture together.
Does Hypopnea Occur in Children?
Yes, hypopnea can also occur in children and typically presents as part of the obstructive sleep apnea syndrome. The most common cause in children is enlarged tonsils and adenoids. This condition, which leads to narrowing of the upper airway, can cause shallow breathing and a drop in oxygen levels during sleep. Snoring, mouth-breathing, restless sleep, and night sweats are among the notable symptoms in children.
In children, hypopnea can affect not only sleep quality but also growth and development. Sleep disrupted throughout the night may manifest as symptoms such as attention deficits, learning difficulties, behavioral issues, and excessive daytime activity. Therefore, it is important for children who snore frequently, have irregular breathing during sleep, or whose daytime performance is affected to undergo a pediatric evaluation. With early diagnosis and appropriate treatment, both sleep patterns and overall development can be positively supported.